Karlsson C et al. |
Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats. |
2015 |
Endocrinology |
pmid:25549047
|
Laezza C et al. |
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. |
2010 |
Endocr. Relat. Cancer |
pmid:20304978
|
Maingret F et al. |
The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. |
2001 |
EMBO J. |
pmid:11226154
|
Chemin J et al. |
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. |
2001 |
EMBO J. |
pmid:11742980
|
van der Stelt M et al. |
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. |
2005 |
EMBO J. |
pmid:16107881
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Battista N et al. |
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24218186
|
Jia Y et al. |
TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. |
2005 |
Drug News Perspect. |
pmid:15915217
|
Sridar C et al. |
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. |
2011 |
Drug Metab. Dispos. |
pmid:21289075
|
Pratt-Hyatt M et al. |
Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. |
2010 |
Drug Metab. Dispos. |
pmid:20702771
|
Ekins S et al. |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. |
2007 |
Drug Metab. Dispos. |
pmid:17194716
|
Muccioli GG |
Endocannabinoid biosynthesis and inactivation, from simple to complex. |
2010 |
Drug Discov. Today |
pmid:20304091
|
Farrell EK and Merkler DJ |
Biosynthesis, degradation and pharmacological importance of the fatty acid amides. |
2008 |
Drug Discov. Today |
pmid:18598910
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Childers SR and Breivogel CS |
Cannabis and endogenous cannabinoid systems. |
1998 Jun-Jul |
Drug Alcohol Depend |
pmid:9716939
|
Welch SP |
Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems. |
1997 |
Drug Alcohol Depend |
pmid:9179505
|
Harada N and Okajima K |
Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats. |
2007 |
Dig. Dis. Sci. |
pmid:17211693
|
Eckardt K et al. |
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. |
2009 |
Diabetologia |
pmid:19089403
|
Mallat A and Lotersztajn S |
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. |
2008 |
Diabetes Metab. |
pmid:19195630
|
Rajesh M et al. |
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. |
2012 |
Diabetes |
pmid:22315315
|
Troy-Fioramonti S et al. |
Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice. |
2015 |
Diabetes |
pmid:25281429
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Buznikov GA et al. |
A putative 'pre-nervous' endocannabinoid system in early echinoderm development. |
2010 |
Dev. Neurosci. |
pmid:19907129
|
Levin M and Mercola M |
Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. |
2000 |
Dev. Dyn. |
pmid:10974676
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Harvey BS et al. |
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. |
2013 |
Cytokine |
pmid:23706402
|
Harvey BS et al. |
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. |
2014 |
Cytokine |
pmid:24238999
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Leweke FM |
Anandamide dysfunction in prodromal and established psychosis. |
2012 |
Curr. Pharm. Des. |
pmid:22716147
|
Di Marzo T et al. |
Endocannabinoids: new targets for drug development. |
2000 |
Curr. Pharm. Des. |
pmid:10903398
|
Palmer SL et al. |
Natural and synthetic endocannabinoids and their structure-activity relationships. |
2000 |
Curr. Pharm. Des. |
pmid:10903399
|
Fowler CJ |
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. |
2008 |
Curr. Pharm. Des. |
pmid:18781976
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
Di Marzo V et al. |
Endovanilloid signaling in pain. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12139983
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. |
1999 |
Curr. Med. Chem. |
pmid:10469888
|
Reggio PH |
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. |
2010 |
Curr. Med. Chem. |
pmid:20166921
|
Di Marzo V and De Petrocellis L |
Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. |
2010 |
Curr. Med. Chem. |
pmid:20166923
|
Ashton JC et al. |
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. |
2008 |
Curr. Med. Chem. |
pmid:18537620
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|
Pate DW et al. |
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. |
1995 |
Curr. Eye Res. |
pmid:8529418
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Rice AS |
Cannabinoids and pain. |
2001 |
Curr Opin Investig Drugs |
pmid:11575713
|
Cravatt BF and Lichtman AH |
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. |
2003 |
Curr Opin Chem Biol |
pmid:12941421
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Guindon J and Beaulieu P |
The role of the endogenous cannabinoid system in peripheral analgesia. |
2009 |
Curr Mol Pharmacol |
pmid:20021453
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Panagis G et al. |
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. |
2008 |
Curr Drug Abuse Rev |
pmid:19630731
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Després JP |
The endocannabinoid system: a new target for the regulation of energy balance and metabolism. |
2007 |
Crit Pathw Cardiol |
pmid:17667864
|
Nilsson O et al. |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. |
2003 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:14659458
|
Guindon J and Hohmann AG |
The endocannabinoid system and pain. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19839937
|
Lambert RC et al. |
Modulation of neuronal T-type calcium channels. |
2006 |
CNS Neurol Disord Drug Targets |
pmid:17168746
|
Khanna IK and Alexander CW |
Fatty acid amide hydrolase inhibitors--progress and potential. |
2011 |
CNS Neurol Disord Drug Targets |
pmid:21631410
|
GarcÃa-GarcÃa F et al. |
Sleep-inducing factors. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19689305
|
Dollery C |
Investigative clinical pharmacology. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21862965
|
Zoerner AA et al. |
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21716266
|
Busch L et al. |
Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16487271
|
Ruginsk SG et al. |
Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion. |
2013 |
Clin. Exp. Pharmacol. Physiol. |
pmid:23875874
|
Barun S et al. |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16173925
|
Mitchell VA et al. |
Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17880375
|
Tuboly G et al. |
Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level. |
2009 |
Clin. Exp. Pharmacol. Physiol. |
pmid:19018802
|
Vogeser M et al. |
Release of anandamide from blood cells. |
2006 |
Clin. Chem. Lab. Med. |
pmid:16599845
|
Schroeder C et al. |
Circulating endocannabinoid concentrations during orthostatic stress. |
2009 |
Clin. Auton. Res. |
pmid:19756829
|
Cui N et al. |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin. |
2017 |
Clin Ther |
pmid:28291580
|
Alenmyr L et al. |
TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. |
2011 |
Clin Physiol Funct Imaging |
pmid:21981454
|
Bátkai S et al. |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. |
2004 |
Circulation |
pmid:15451779
|
Hong Z et al. |
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. |
2006 |
Circulation |
pmid:16982938
|
Gurney AM et al. |
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. |
2003 |
Circ. Res. |
pmid:14551239
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
Ahn K et al. |
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. |
2008 |
Chem. Rev. |
pmid:18429637
|
Xie S et al. |
Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. |
2010 |
Chem. Res. Toxicol. |
pmid:21049984
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Di Scala C et al. |
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells. |
2017 |
Chem. Phys. Lipids |
pmid:28389107
|
Palmer SL et al. |
Cannabinergic ligands. |
2002 |
Chem. Phys. Lipids |
pmid:12505686
|
Razdan RK and Mahadevan A |
Recent advances in the synthesis of endocannabinoid related ligands. |
2002 |
Chem. Phys. Lipids |
pmid:12505687
|
Kunos G et al. |
The quest for a vascular endothelial cannabinoid receptor. |
2002 |
Chem. Phys. Lipids |
pmid:12505689
|
Wiley JL and Martin BR |
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. |
2002 |
Chem. Phys. Lipids |
pmid:12505690
|
Schmid HH et al. |
Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. |
2002 |
Chem. Phys. Lipids |
pmid:12505695
|
Cravatt BF and Lichtman AH |
The enzymatic inactivation of the fatty acid amide class of signaling lipids. |
2002 |
Chem. Phys. Lipids |
pmid:12505696
|
Paria BC et al. |
Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. |
2002 |
Chem. Phys. Lipids |
pmid:12505701
|
Sandberg A and Fowler CJ |
Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. |
2005 |
Chem. Phys. Lipids |
pmid:15784231
|
Kotsikorou E et al. |
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55. |
2011 |
Chem. Phys. Lipids |
pmid:21185816
|
Reggio PH and Traore H |
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. |
2000 |
Chem. Phys. Lipids |
pmid:11106780
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Schmid HH |
Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? |
2000 |
Chem. Phys. Lipids |
pmid:11106783
|
Hillard CJ and Jarrahian A |
The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. |
2000 |
Chem. Phys. Lipids |
pmid:11106786
|
Kunos G et al. |
Endocannabinoids as cardiovascular modulators. |
2000 |
Chem. Phys. Lipids |
pmid:11106789
|
Schmid PC et al. |
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. |
1997 |
Chem. Phys. Lipids |
pmid:9275307
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
Oddi S et al. |
Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. |
2009 |
Chem. Biol. |
pmid:19481477
|
Ahn K et al. |
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. |
2009 |
Chem. Biol. |
pmid:19389627
|
Godlewski G et al. |
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. |
2010 |
Chem. Biol. |
pmid:21095576
|
Shekhar C |
Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges. |
2011 |
Chem. Biol. |
pmid:21609833
|
Blankman JL et al. |
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. |
2007 |
Chem. Biol. |
pmid:18096503
|
Imming P |
Fatty pain cures. |
2007 |
Chem. Biol. |
pmid:18096498
|
King AR et al. |
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. |
2007 |
Chem. Biol. |
pmid:18096504
|
Hanus LO |
Discovery and isolation of anandamide and other endocannabinoids. |
2007 |
Chem. Biodivers. |
pmid:17712821
|
Okamoto Y et al. |
Biosynthetic pathways of the endocannabinoid anandamide. |
2007 |
Chem. Biodivers. |
pmid:17712822
|